NPI: 1710949847 · GREENWOOD, SC 29646 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/04/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/04/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 9,306 | $251K |
| 2019 | 19,848 | $156K |
| 2020 | 21,050 | $160K |
| 2021 | 14,360 | $74K |
| 2022 | 10,970 | $62K |
| 2023 | 7,097 | $81K |
| 2024 | 4,590 | $68K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90935 | Hemodialysis procedure with single evaluation by a physician | 32,375 | 3,146 | $488K |
| A4657 | Syringe, with or without needle, each | 5,889 | 2,677 | $188K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 11,944 | 2,013 | $126K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 4,717 | 787 | $20K |
| J1756 | Injection, iron sucrose, 1 mg | 4,752 | 1,523 | $9K |
| S9339 | Home therapy; peritoneal dialysis, administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem | 2,644 | 217 | $6K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 421 | 223 | $6K |
| J1270 | Injection, doxercalciferol, 1 mcg | 13,263 | 1,608 | $3K |
| 83970 | 2,378 | 1,894 | $2K | |
| 82728 | 1,344 | 1,155 | $517.42 | |
| 83550 | 1,254 | 1,091 | $401.15 | |
| 83540 | 1,352 | 1,159 | $367.37 | |
| 90674 | 67 | 64 | $254.97 | |
| 82108 | 381 | 344 | $245.04 | |
| 85048 | 1,859 | 1,594 | $169.39 | |
| 85041 | 1,900 | 1,619 | $165.88 | |
| 90662 | 67 | 58 | $70.74 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 461 | 242 | $29.24 |
| G0008 | Administration of influenza virus vaccine | 125 | 111 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 16 | 12 | $0.00 |
| 0124A | 12 | 12 | $0.00 |